Microbot Medical Inc. MBOT
1.28
(0.03)
(2.29%)
as of 25 Sep
- Market cap
- $88.0M
- P/E
- 0.0×
Follow MBOT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
23.33 | 2.37 | 2.09 | 4.26 | 8.00 | 18.78 | 7.45 | 1.23 | 20.70 | 4.23 |
Net Debt/EBITDA |
5.35 | 0.48 | 0.66 | 0.61 | 1.35 | 2.67 | 4.88 | 0.73 | 2.06 | 0.27 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.88% | 2.40% | 2.38% | 2.05% | 0.00% | 0.00% | 2.26% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.03 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.99 | 0.77 | 0.79 | 0.88 | 0.83 | 0.79 | 0.89 | 0.73 | 0.81 | 0.14 |
Capex/Depreciation |
(1.28) | (0.27) | (0.31) | (0.82) | (0.91) | (1.34) | 0.51 | (4.13) | (2.76) | (2.50) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (32.42%) | (284.97%) | (182.19%) | (121.53%) | (58.48%) | (32.84%) | (44.09%) | (123.11%) | (94.90%) | (558.34%) | |
| (30.01%) | (159.40%) | (120.24%) | (100.12%) | (52.56%) | (28.92%) | (33.54%) | (84.86%) | (83.50%) | (292.99%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (2,812.19%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(17.18%) | (332.74%) | (250.88%) | (189.03%) | (80.01%) | (37.95%) | (23.13%) | (545.86%) | (57.25%) | (220.85%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.29) | (0.57) | (0.84) | (1.60) | (1.33) | (1.03) | (1.50) | (1.91) | (2.26) | (0.85) |
Cash per Share |
1.72 | 0.35 | 0.63 | 1.14 | 2.19 | 3.47 | 8.35 | 1.81 | 4.96 | 2.84 |
Shareholders Equity per Share |
1.69 | 0.23 | 0.44 | 1.00 | 2.02 | 3.42 | 7.39 | 0.46 | 4.80 | 2.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.69 | 0.23 | 0.44 | 1.00 | 2.02 | 3.42 | 7.39 | 0.46 | 4.80 | 2.30 |
Free Cash Flow |
(13.11) | (8.85) | (8.57) | (11.63) | (9.42) | (7.34) | (6.41) | (5.53) | (4.91) | (0.81) |
Working Capital |
76.40 | 3.36 | 4.14 | 6.75 | 13.90 | 23.91 | 31.11 | 1.07 | 10.40 | 2.53 |
Capital Expenditures |
(0.06) | (0.02) | (0.03) | (0.08) | (0.07) | (0.09) | 0.04 | (0.22) | (0.06) | (0.02) |
Net Current Asset Value |
75.83 | 3.32 | 4.10 | 6.57 | 13.49 | 23.28 | 30.35 | 1.07 | 10.37 | 2.14 |
| Other line items | ||||||||||
Quick Ratio |
22.97 | 2.24 | 2.05 | 4.05 | 7.94 | 18.64 | 7.41 | 1.12 | 20.55 | 3.48 |
Depreciation/Fixed assets |
0.51 | 1.14 | 0.73 | 0.46 | 0.31 | 0.27 | 0.37 | 0.21 | 0.23 | 0.19 |
Cash ROIC |
(8.41%) | (98.43%) | (79.37%) | (74.73%) | (31.61%) | (15.11%) | (9.83%) | (84.47%) | (23.24%) | (16.84%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.28) | (0.56) | (0.84) | (1.59) | (1.32) | (1.02) | (1.51) | (1.83) | (2.23) | (0.82) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.01) | 0.01 | (0.08) | (0.03) | (0.03) |
Average Receivables |
— | — | 0.72 | 0.14 | 0.26 | 0.22 | 0.08 | 0.05 | 0.03 | 0.03 |
Average Payables |
0.34 | 0.26 | 0.24 | 0.20 | 0.28 | 0.28 | 0.46 | 0.35 | 0.30 | 0.27 |
Average Assets |
43.79 | 7.18 | 8.93 | 13.15 | 21.52 | 31.70 | 21.61 | 8.56 | 7.19 | 1.95 |
Average Common Equity |
40.54 | 4.02 | 5.90 | 10.84 | 19.34 | 27.92 | 16.44 | 5.90 | 6.33 | 1.02 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates